On Invalid Date, Johnson & Johnson (NYSE: JNJ) reported Q3 2022 earnings per share (EPS) of $1.70, up 22.3% year over year. Total Johnson & Johnson earnings for the quarter were $4.46 billion. In the same quarter last year, Johnson & Johnson's earnings per share (EPS) was $1.39.
As of Q1 2023, Johnson & Johnson's earnings has grown 7.51% year over year. This is 32 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 39.51%. Johnson & Johnson's earnings in the past year totalled $19.16 billion.
What was JNJ's revenue last quarter?
On Invalid Date, Johnson & Johnson (NYSE: JNJ) reported Q3 2022 revenue of $23.79 billion up 1.94% year over year. In the same quarter last year, Johnson & Johnson's revenue was $23.34 billion.
What was JNJ's revenue growth in the past year?
As of Q1 2023, Johnson & Johnson's revenue has grown 5.02% year over year. This is 7.34 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 12.36%. Johnson & Johnson's revenue in the past year totalled $96.04 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.